A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation)
Clinical trial NCT04111458 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04111458
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-04
- Primary completion
- 2028-03-31
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.